• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION VALVE CONDUIT CONTEGRA; CONDUIT,VALVED,PULMONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION VALVE CONDUIT CONTEGRA; CONDUIT,VALVED,PULMONIC Back to Search Results
Model Number PVC222
Device Problems Calcified (1077); Gradient Increase (1270); Material Deformation (2976); Material Twisted/Bent (2981)
Patient Problem Hematoma (1884)
Event Date 02/10/2004
Event Type  Injury  
Event Description
Medtronic received information via a journal article in the annals of thoracic surgery regarding a study of 67 patients who were discharged april 1999 to december 2003 after implantation of a contegra conduit.Patient demographics: mean age 16.1 years (range 2 months to 53 years), mean weight 39.7kg (range 4 to 95kg).Conduit size was 14mm (n=2), 16mm (n=7), 18mm (n=12), 20mm (n=13), 22mm (n=33).Mean follow-up of 26.4 months (range 1 to 56 months) revealed the following adverse events related to the device: - twisted conduits (n=2, 22mm devices): the authors indicated that these twisted conduits were due to technical problems at implant, and concluded that they were "correlated with the learning curve in the use of this type of conduit, which is much more soft and pliable than the conventional homograft and therefore less forgiving with regard to potential twisting." patient #1: the conduit was explanted and replaced 16 months post-implant.It was reported that the device was twisted between the v alve and the distal anastomosis, with an internal diameter equal to 50% of the recorded proximal and distal values, corresponding to a peak pressure gradient of 27mmhg and mean gradient of 24mmhg (see fig.2 in the attached article).Patient #2: 1 month post-implant a stent was implanted in the conduit proximal to the valve.The conduit was not explanted.- conduit compression (n=1, 22mm): 3 months post-implant, extrinsic conduit compression, speculated to be due to a hematoma, was treated with a stent implantation between the valve and the distal anastomosis.Electrocardiogram-gated multi-slice computer tomography (ecg-gated msct) indicated a 30% reduction of the internal diameter distal to the conduit valve.The patient had a small calcification (2.3mm diameter) detected in the conduit wall (fig.3).Citation: authors: antonio f.Corno, md, frcs, salah d.Qanadli, md, phd, nicole sekarski, md, simona artemisia, md, michel hurni, md, piergiorgio tozzi, md, and ludwig k.Von segesser, md, facs journal name: annals of thoracic surgery year: 2004 issue #: 78:1382¿8 title of article: bovine valved xenograft in pulmonary position: medium-term follow-up with excellent hemodynamics and freedom from calcification literature reference #: doi:10.1016/j.Athoracsur.2004.02.095.
 
Manufacturer Narrative
Endocarditis, stenosis/high gradients, calcification, and regurgitation are known adverse events for this device.The sterilization process used by medtronic has an anti-microbial kill on the microorganisms such as staphylococcus and streptococcus species.Also, the sterilization process has an anti-microbial kill for our process which is validated using the worst case bacillus atrophaeus (gram-positive spore forming rods), which is known to be representative of the cleanroom bioburden and our process is validated is effective.As reported, the observed twisted conduits were attributed to technical problems and level of implanter experience.A query of medtronic¿s databases five years did not reveal any other customer complaints regarding this type of observation.A device history records review could not be performed, as the serial numbers were not provided.To date, no additional information has been provided by the article¿s author contact.Based on the limited information received, a true root cause to the clinical observations cannot be determined.
 
Manufacturer Narrative
Without the return of the product, no definitive conclusion can be made regarding the clinical observations.(b)(4).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALVE CONDUIT CONTEGRA
Type of Device
CONDUIT,VALVED,PULMONIC
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 east deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4258571
MDR Text Key4990442
Report Number2025587-2014-00902
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,foreign,health profe
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/05/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVC222
Device Catalogue NumberPVC222
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/05/2014
Initial Date FDA Received11/18/2014
Supplement Dates Manufacturer ReceivedNot provided
12/05/2014
Supplement Dates FDA Received12/09/2014
09/15/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00016 YR
Patient Weight39
-
-